TONS of things cure cancer. All day, every day. Doctors have no clue what cancer is. All they can do is cut, burn, or poison and cross their fingers.

I didn't say Cannabis was THE cure. It is A cure used by thousands with amazing efficacy. Everyone is different.

Here's 60+ studies for your perusal if you insist on the superiority of western scientific research:

"Cannabis, and the cannabinoid compounds found within it, has been shown through a large cannabisplantamount of scientific, peer-reviewed research to be effective at treating a wide variety of cancers, ranging from brain cancer to colon cancer. Below is a list of over 60 studies that demonstrate the vast anti-cancer properties of cannabis.
Studies showing cannabis may combat brain cancer:
Cannabidiol (CBD) inhibits the proliferation and invasion in U87-MG and T98G glioma cells. Study published in the Public Library of Science journal in October 2013.
Tetrahydrocannabinol (THC) can kill cancer cells by causing them to self-digest. Study published in the Journal of Clinical Investigation in September 2013.
CBD is a novel therapeutic target against glioblastoma. Study published in Cancer Research in March 2013.
Local delivery of cannabinoid-filled microparticles inhibits tumor growth in a model of glioblastoma multiforme. Study published in Public Library of Science in January 2013.
Cannabinoid action inhibits the growth of malignant human glioma U87MG cells. Study published in Oncology Reports in July 2012.
Cannabidiol enhances the inhibitory effects of THC on human glioblastoma cell proliferation and survival. Study published in the Molecular Cancer Therapeutics journal in January 2010.
Cannabinoid action induces autophagy-mediated cell death in human glioma cells. Study published in The Journal of Clinical Investigation in May 2009.
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Study published in Cancer Research in March 2008.
Cannabinoids and gliomas. Study published in Molecular Neurobiology in June 2007.
Cannabinoids inhibit gliomagenesis. Study published in the Journal of Biological Chemistry in March 2007.
A pilot clinical study of THC in patients with recurrent glioblastoma multiforme. The results were published in the British Journal of Cancer in June 2006.
Cannabidiol inhibits human glioma cell migration through an independent cannabinoid receptor mechanism. Study published in the British Journal of Pharmacology in April 2005.
Cannabinoids inhibit the vascular endothelial growth factor pathway (VEGF) in gliomas. Study published in the Journal of Cancer Research in August 2004.
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. Study published in the Journal of Pharmacology in November 2003.
Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. Study published in the Journal of Cancer Research in August 2001.
Studies showing cannabis may combat colorectal cancer:
Cannabigerol (CBG) can inhibit colon cancer cells. Study published in the Oxford journal Carcinogenesis in October 2014.
Inhibition of colon carcinogenesis by a standardised Cannabis Sativa extract with high content of CBD. Study published in Phytomedecine in December 2013.
Chemopreventive effect of the non-psychotropic phytocannabinoid CBD on colon cancer. Study published in the Journal of Molecular Medecine in August 2012.
Cannabinoids against intestinal inflammation and cancer. Study published in Pharmacology Research in August 2009.
Action of cannabinoid receptors on colorectal tumor growth. Study published by the Cancer Center of the University of Texas in July 2008.
Studies showing cannabis may combat blood cancer:
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. Study published in the International Journal of Cancer in December 2013.
Enhancing the activity of CBD and other cannabinoids against leukaemia. Study published in Anticancer Research in October 2013.
Cannabis extract treatment for terminal acute lymphoblastic leukemia of Philadelphia chromosome (Ph1). Study published in Case Reports in Oncology in September 2013.
Expression of type 1 and type 2 cannabinoid receptors in lymphoma. Study published in the International Journal of Cancer in June 2008.
Cannabinoid action in mantle cell lymphoma. Study published in Molecular Pharmacology in November 2006.
THC-induced apoptosis in Jurkat leukemia. Study published in Molecular Cancer Research in August 2006.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Study published in Blood American Society of Hemmatology in July 2002.
Studies showing cannabis can combat lung cancer:
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of Icam-1. Study published in Biochemical Pharmacology in July 2014.
Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Study published in Biochemical Pharmacology in June 2014.
COX-2 and PPAR-γ confer CBD-induced apoptosis of human lung cancer cells. Study published in Molecular Cancer Therapeutics in January 2013.
CBD inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. Study published in the Journal of the Federation of American Societies for Experimental Biology in April 2012.
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non–small cell lung cancer growth and metastasis. Study published in Cancer Prevention Research in January 2011.
THC inhibits epithelial growth factor-induced (EGF) lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Study published in the journal Oncogene in July 2007.
Studies showing cannabis may combat stomach cancer:
Cannabinoid receptor agonist as an alternative drug in 5-Fluorouracil-resistant gastric cancer cells. Study published in Anticancer Research in June 2013.
Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells. Study published in the Journal of Cellular Biochemistry in March 2011.
Studies showing cannabis may combat prostrate cancer:
Cannabinoids can treat prostate cancer. Study published by the National Institute of Health in October 2013.
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Study published in the British Journal of Pharmacology in December 2012.
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. Study published in the Indian Journal of Urology in January 2012.
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Study published in Anticancer Research in November 2011.
Studies showing cannabis may combat liver cancer:
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma (CHC). Study published in Cell Death and Disease in May 2013.
Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells. Study published on the site Informa Healthcare in February 2013.
Antitumoral action of cannabinoids on hepatocellular carcinoma. Study published in Cell Death and Differentiation in April 2011.
Studies showing cannabis may combat pancreatic cancer:
Cannabinoids inhibit energetic metabolism and induce autophagy in pancreatic cancer cells. Study published in Cell Death and Disease in June 2013.
Cannabinoids Induce apoptosis of pancreatic tumor cells. Study published in Cancer Research in July 2006.
Studies showing cannabis may combat skin cancer:
Cannabinoid receptor activiation can combat skin cancer. Study published by the National Institute of Health in October 2013.
Cannabinoids were found to reduce skin cancer by 90% in just 2 weeks. Study published in the Journal of Pharmacy and Pharmacology in July 2013.
Cannabinoid receptors as novel targets for the treatment of melanoma. Study published in the Journal of the Federation of American Societies for Experimental Biology in December 2006.
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. Study published in the Journal of Clinical Investigation, in January 2003.
Studies showing cannabis may combat other types of cancer:
Bladder: Marijuana reduces the risk of bladder cancer. Study published in the Medscape site in May 2013.
Kaposi sarcoma: Cannabidiol inhibits growth and induces programmed cell death in Kaposi sarcoma–associated herpesvirus-infected endothelium. Study published in the journal Genes & Cancer in July 2012.
Nose, mouth, throat, ear: Cannabinoids like THC inhibit cellular respiration of human oral cancer cells. Study by the Department of Pediatrics at the State University of New York, published in June 2010.
Bile duct: The dual effects of THC on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Study published in Cancer Investigation in May 2010.
Ovaries: Cannabinoid receptors as a target for therapy of ovarian cancer. Study published on the American Association for Cancer Research website in 2006.
Preparation and characterisation of biodegradable microparticles filled with THC and their antitumor efficacy on cancer cell lines. Study published in the Journal of Drug Targeting in September 2013.
CBD Cannabidiol as a potential anticancer drug. Study published in the British Journal of Pharmacology in February 2013.
Cannabinoids as anticancer modulators. Study published in the Progress in Lipid Research journal in January 2013.
CBD inhibits angiogenesis by multiple mechanisms. Study published in the British Journal of Pharmacology in November 2012.
Towards the use of cannabinoids as antitumour agents. Study published in Nature in June 2012.
Cannabinoid-associated cell death mechanisms in tumor models. Study published in the International Journal of Oncology in May 2012.
Cannabinoids, endocannabinoids and cancer. Study published in Cancer Metastasis Reviews in December 2011.
The endocannabinoid system and cancer: therapeutic implication. Study published in the British Journal of Pharmacology in July 2011.
This list was compiled in part by Alchimiaweb.com.
– TheJointBlog"

This video has been seconded as a duplicate; transferring votes to the original video and killing this dupe - dupeof seconded with isdupe by messenger.

Tags for this video have been changed from 'tsunami, footage, march 2011, tsunami 2011' to 'tsunami, footage, march 2011, tsunami 2011, cctv' - edited by messenger

looks like a *dupeof=http://videosift.com/video/Previously-Unseen-Tsunami-Footage-March-2011

This video has been nominated as a duplicate of this video by eric3579. If this nomination is seconded with *isdupe, the video will be killed and its votes transferred to the original.

Tags for this video have been changed from 'tsunami, footage, march 2011' to 'tsunami, footage, march 2011, tsunami 2011' - edited by lucky760

@ghark
@notarobot

I recall news reporting just prior to military intervention in Libya was suggesting that Gaddafi's forces were approaching Benghazi and there were expectations of massacre if they were to reach it.

Wikipedia for what it's worth:

http://en.wikipedia.org/wiki/2011_military_intervention_in_Libya

"9 March 2011: The head of the Libyan National Transitional Council, Mustafa Abdul Jalil, "pleaded for the international community to move quickly to impose a no-fly zone over Libya, declaring that any delay would result in more casualties".[38] Three days later, he stated that if pro-Gaddafi forces reached Benghazi, then they would kill "half a million" people. He stated, "If there is no no-fly zone imposed on Gaddafi's regime, and his ships are not checked, we will have a catastrophe in Libya."[39]"

"17 March 2011: The UN Security Council, acting under the authority of Chapter VII of the UN Charter, approved a no-fly zone by a vote of ten in favour, zero against, and five abstentions, via United Nations Security Council Resolution 1973. The five abstentions were: Brazil, Russia, India, China, and Germany.[49][50][51][60][61] Less than twenty-four hours later, Libya announced that it would halt all military operations in response to the UN Security Council resolution.[62][63]"

This video got me interested in exactly why 10 000 Japanese people would choose to perform a notoriously difficult piece, in German.

The Japanese call the piece Daiku and perform it every year in December. The largest of these gatherings is most likely the one in this video, "Suntory Presents Beethoven's 9th with a Cast of 10000," in the Osaka Castle Hall. It could also be the special concert from December 2011 which was dedicated to victims of the March 2011 earthquake and tsunami, and in fact the pictures of that event look quite like this video.

It turns out that it is because in the first world war Japan was allied with Britain, and ended up with some German prisoners of war in Japan. In June 1918, German POWs gave a legendary concert in Naruto, Tokushima Prefecture, where they played the Ninth. Since then it has become quite popular in Japan.

There is an article from 2010 in www.japantimes.co.jp on this subject.

>> ^darkrowan:

For all the goofieness of this vid it does bring up a good question: Who's replacing them? Could be, like The Who said, "Meet the new boss, same as the old boss"?


Seems to be, unlike popular uprisings in some other countries which have resulted in the overthrow of a dictator by the people, this has been paid gangs of thugs backed by NATO airstrikes dealing with Qadhafi and any local resistance. What seems most worrisome is the National Transitional Councils decision to give policy decision making authority out to corporations, for example:
Monetary policy is handled by the Central Bank of Benghazi
http://www.ntclibya.org/english/meeting-on-19-march-2011/

..and oil policy is handled by... The Libyan Oil Company.
http://www.bloomberg.com/news/2011-03-21/libyan-rebel-council-sets-up-oil-company-to-replace-qaddafi-s.html

Pretty much the same as if Bank of America were given full authority to handle all policy decisions for America's banking system, or if Exxon Mobil got to make all fossil fuel and environmental policy.

"Bradley E. Manning (born December 17, 1987) is a United States Army soldier who was arrested in May 2010 in Iraq on suspicion of having passed restricted material to the website WikiLeaks. He was charged in July that year with transferring classified data onto his personal computer, and communicating national defense information to an unauthorized source. An additional 22 charges were preferred in March 2011, including "aiding the enemy," a capital offense, though prosecutors said they would not seek the death penalty. He currently awaits a hearing to decide whether he will face a court martial.[2]" http://en.wikipedia.org/wiki/Bradley_Manning

So he's been locked up with no trial, only charges, for a full year (almost).

Not to mention that very shabby conditions he's being held in, which to me seem obviously punitive, which is illegal.
>> ^Morganth:

He does though. They can't just give you a trail date immediately when you're arrested. His trail date is within the next two months.>> ^gwiz665:
But here's the kicker - Manning hasn't been tried for anything. Not found guilty of anything. He has just been imprisoned.
In a society of law, this can't be right.
>> ^SDGundamX:
I think there are two separate issues here: breaking the law and morally doing the right thing. They're not always the same. Obama's answer shouldn't be shocking to anyone because from the government's standpoint Manning did indeed break the law. So did Daniel Ellsberg. The only reason Ellsberg wasn't convicted in fact was because of the gross misconduct of the government during the prosecution of his case, which resulted in a mistrial. But Ellsberg freely admits to knowing he was breaking the law and expecting to go to prison--he did it because he felt it was the right thing to do.
If someone with access to classified or top secret information mentions--even in a casual conversation--anything about the materials they have access to, they know they are going to go to be arrested and tried. That's what the law says. The law has said that since the Espionage Act of 1917. If people disagree with it, they need to lobby to have the law either amended or repealed. To be fair though, the law has been used successfully many times to prosecute actual spies and others who tried to make a profit by selling classified materials. I think given the circumstances, though, the law needs to be updated somehow to account for whistle-blowers.

>> ^radx:

Haha, the last one is epic if it really was on the tele.


In the Netherlands, I think, but yes it was. http://videosift.com/video/Cunning-Lingo-ist

Your video, Win Compilation February March 2011, has made it into the Top 15 New Videos listing. Congratulations on your achievement. For your contribution you have been awarded 1 Power Point.